04:37 PM EDT, 08/20/2024 (MT Newswires) -- Nathan J Dowden, President & COO, on August 16, 2024, sold 27,097 shares in Entrada Therapeutics ( TRDA ) for $440,801. Following the Form 4 filing with the SEC, Dowden has control over a total of 130,107 shares of the company, with 130,107 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1689375/000168937524000048/xslF345X03/wk-form4_1724186017.xml